Literature DB >> 15992755

Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.

John O Mason1, Cheri T Colagross, Troy Haleman, Jeffrey J Fuller, Milton F White, Richard M Feist, Tracy L Emond, Gerald McGwin.   

Abstract

PURPOSE: To assess the visual outcome following vitrectomy for diabetic retinopathy compared with previous studies; to evaluate risk factors for light perception (LP) and no light perception (NLP) vision after diabetic vitrectomy.
DESIGN: Retrospective medical record review.
METHODS: The charts of 100 consecutive patients who underwent vitrectomy for proliferative diabetic retinopathy between November 1, 1997, and November 30, 1998, were reviewed. Surgical technique included standard pars plana vitrectomy with combination of delamination and segmentation of gliotic tractional membranes using bimanual techniques. All patients had post-operative follow-up of at least 12 months. Several factors were analyzed for their effect on poor visual outcome (LP and NLP) using Fisher's exact test.
RESULTS: Post-vitrectomy, 73% of diabetic patients had stable or improved vision; 16% had worsened but functional vision, defined as worse but still >or= 20/400; 4% had worsened but ambulatory vision, defined as worse but still count fingers (CF) or hand motion (HM); and 7% had poor visual outcome, LP or NLP. Resultant visual acuity was >or=20/40 in 38% of patients, 20/50 to 20/100 in 34%, 20/120 to CF in 18%, HM in 3%, LP in 4%, and NLP in 3%. Risk factors for eyes with LP and NLP vision included pre-operative iris neovascularization (INV), P = .05, post-operative INV, P = .02, post-operative macular ischemia, P = .0001, and post-operative vitreous hemorrhage (VH), P = .02.
CONCLUSIONS: Pre-operative and post-operative INV, post-operative macular ischemia, and post-operative VH appear to be risk factors for LP and NLP vision following diabetic vitrectomy, whereas overall improvements in surgical technique and visual outcome continue to be reported.

Entities:  

Mesh:

Year:  2005        PMID: 15992755     DOI: 10.1016/j.ajo.2005.02.052

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy.

Authors:  Matthew R Ritter; Eyal Banin; Stacey K Moreno; Edith Aguilar; Michael I Dorrell; Martin Friedlander
Journal:  J Clin Invest       Date:  2006-11-16       Impact factor: 14.808

2.  Bevacizumab prior to vitrectomy for diabetic traction retinal detachment.

Authors:  R Pokroy; U R Desai; E Du; Y Li; P Edwards
Journal:  Eye (Lond)       Date:  2011-07-08       Impact factor: 3.775

3.  Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats.

Authors:  Zhikun Yang; Kanghua Li; Xi Yan; Fangtian Dong; Chunhua Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

Review 4.  Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Authors:  Jaafar El Annan; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

5.  Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study.

Authors:  B Gupta; S Sivaprasad; R Wong; A Laidlaw; T L Jackson; D McHugh; T H Williamson
Journal:  Eye (Lond)       Date:  2012-01-06       Impact factor: 3.775

Review 6.  New Therapeutic Approaches in Diabetic Retinopathy.

Authors:  Kamyar Vaziri; Stephen G Schwartz; Nidhi Relhan; Krishna S Kishor; Harry W Flynn
Journal:  Rev Diabet Stud       Date:  2015-08-10

7.  Surgical outcomes of vitrectomy surgery for proliferative diabetic retinopathy in patients with abnormal renal function.

Authors:  P Larrañaga-Fragoso; H Laviers; C McKechnie; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-22       Impact factor: 3.117

8.  Characteristics and Outcomes of Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy Patients in a Limited Resource Tertiary Center over an Eight-Year Period.

Authors:  Janejit Choovuthayakorn; Preeyanuch Khunsongkiet; Direk Patikulsila; Nawat Watanachai; Paradee Kunavisarut; Voraporn Chaikitmongkol; Nimitr Ittipunkul
Journal:  J Ophthalmol       Date:  2019-03-17       Impact factor: 1.909

Review 9.  Current and novel multi-imaging modalities to assess retinal oxygenation and blood flow.

Authors:  Michael J Marino; Peter L Gehlbach; Abhishek Rege; Kim Jiramongkolchai
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 4.456

Review 10.  Current management of diabetic tractional retinal detachments.

Authors:  Michael W Stewart; David J Browning; Maurice B Landers
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.